The remaining threeDSIP, Semax and Epitalonare up for a vote today, Friday, July 24
Whats different here is that a growing number of people are intentionally staying at sub-therapeutic doses long-term, rather than using low doses as a stepping stone to higher ones
It is important to note that whilst blood test results may normalise relatively quickly, symptom resolution often takes longer
"MOTS-c levels in human blood decline with age and correlate with insulin sensitivity, positioning the peptide not just as a metabolic tool but as a potential biomarker of mitochondrial vitality." On the exercise side, a pivotal finding came from studies measuring endogenous MOTS-c in human subjects
Gender Differences in the Context of Obstructive Sleep Apnea and Metabolic Diseases Allen, J., & Bradley, R.D